Sponsored Webinar: At the Crossroads of NAD+ and Long COVID - Emerging Data on Nutrition Interventions (Recording)

Free to all!

Long COVID affects millions, with symptoms like fatigue, brain fog, and breathlessness lasting months post-infection. About 15% still experience symptoms a year later, driving urgent demand for effective treatments.

Niagen Bioscience co-funded a randomized, double-blind, placebo-controlled trial to evaluate NR (nicotinamide riboside) supplementation’s impact on NAD+ levels and long COVID symptoms.

Join us to explore the science behind NR and NAD+ in long COVID.

Sponsored by Niagen Bioscience, Inc.

 

Speakers

Impact of SARS-CoV-2 infection on NAD+ Metabolism: Implications for Long COVID
Charles Brenner, PhD
City of Hope

NAD+ Repletion for Long COVID: A Practitioner Perspective
Chris Meletis, ND
Naturopathic Doctor, Educator, International Author, and Lecturer

 

Learning Objectives

  1. Describe the role of NAD+ in the response to metabolic stress, including viral infection
  2. Explore the relationship between long COVID symptoms and NAD+ metabolism
  3. Describe the design and results of a recent intervention study involving nicotinamide riboside (NR) in individuals with Long COVID
  4. Review the healthcare practitioner perspective on the management of Long COVID
Course summary
Available credit: 
  • 1.50 Attendance

    Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.

Course opens: 
01/18/2026
Course expires: 
01/15/2028
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.50 Attendance

    Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.

Price

Cost:
$0.00
Please login or register to take this course.